ReviewOncoTargets and therapy2018

Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy.

Ellen Weisberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.